6-16327684-ATGCTGCTGCTGCTGCTGCTGCTGCTGCTGC-ATGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGC

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP3BP6_ModerateBA1

The NM_001128164.2(ATXN1):​c.621_626dupGCAGCA​(p.Gln207_Gln208dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.089 ( 573 hom., cov: 20)
Exomes 𝑓: 0.059 ( 2232 hom. )
Failed GnomAD Quality Control

Consequence

ATXN1
NM_001128164.2 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Likely benign criteria provided, single submitter B:2

Conservation

PhyloP100: 0.106

Publications

0 publications found
Variant links:
Genes affected
ATXN1 (HGNC:10548): (ataxin 1) The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes. ADCAII, which always presents with retinal degeneration (SCA7), and ADCAIII often referred to as the `pure' cerebellar syndrome (SCA5), are most likely homogeneous disorders. Several SCA genes have been cloned and shown to contain CAG repeats in their coding regions. ADCA is caused by the expansion of the CAG repeats, producing an elongated polyglutamine tract in the corresponding protein. The expanded repeats are variable in size and unstable, usually increasing in size when transmitted to successive generations. The function of the ataxins is not known. This locus has been mapped to chromosome 6, and it has been determined that the diseased allele contains 40-83 CAG repeats, compared to 6-39 in the normal allele, and is associated with spinocerebellar ataxia type 1 (SCA1). Alternative splicing results in multiple transcript variants, with one variant encoding multiple distinct proteins, ATXN1 and Alt-ATXN1, due to the use of overlapping alternate reading frames. [provided by RefSeq, Nov 2017]
ATXN1 Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia type 1
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_001128164.2
BP6
Variant 6-16327684-A-ATGCTGC is Benign according to our data. Variant chr6-16327684-A-ATGCTGC is described in ClinVar as Likely_benign. ClinVar VariationId is 3057230.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.104 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001128164.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATXN1
NM_001128164.2
MANE Select
c.621_626dupGCAGCAp.Gln207_Gln208dup
disruptive_inframe_insertion
Exon 7 of 8NP_001121636.1
ATXN1
NM_000332.4
c.621_626dupGCAGCAp.Gln207_Gln208dup
disruptive_inframe_insertion
Exon 8 of 9NP_000323.2
ATXN1
NM_001357857.2
c.*34_*39dupGCAGCA
3_prime_UTR
Exon 8 of 9NP_001344786.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATXN1
ENST00000436367.6
TSL:1 MANE Select
c.621_626dupGCAGCAp.Gln207_Gln208dup
disruptive_inframe_insertion
Exon 7 of 8ENSP00000416360.1
ATXN1
ENST00000244769.8
TSL:1
c.621_626dupGCAGCAp.Gln207_Gln208dup
disruptive_inframe_insertion
Exon 8 of 9ENSP00000244769.3
ATXN1
ENST00000642969.1
c.*34_*39dupGCAGCA
downstream_gene
N/AENSP00000493530.1

Frequencies

GnomAD3 genomes
AF:
0.0887
AC:
11926
AN:
134478
Hom.:
569
Cov.:
20
show subpopulations
Gnomad AFR
AF:
0.0965
Gnomad AMI
AF:
0.0394
Gnomad AMR
AF:
0.0992
Gnomad ASJ
AF:
0.0324
Gnomad EAS
AF:
0.0106
Gnomad SAS
AF:
0.113
Gnomad FIN
AF:
0.0969
Gnomad MID
AF:
0.0761
Gnomad NFE
AF:
0.0881
Gnomad OTH
AF:
0.0937
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0587
AC:
75114
AN:
1278760
Hom.:
2232
Cov.:
32
AF XY:
0.0592
AC XY:
37641
AN XY:
635340
show subpopulations
African (AFR)
AF:
0.0686
AC:
1747
AN:
25478
American (AMR)
AF:
0.0703
AC:
2417
AN:
34370
Ashkenazi Jewish (ASJ)
AF:
0.0202
AC:
495
AN:
24468
East Asian (EAS)
AF:
0.00680
AC:
208
AN:
30578
South Asian (SAS)
AF:
0.0861
AC:
6203
AN:
72076
European-Finnish (FIN)
AF:
0.0836
AC:
3317
AN:
39678
Middle Eastern (MID)
AF:
0.0377
AC:
169
AN:
4486
European-Non Finnish (NFE)
AF:
0.0577
AC:
57407
AN:
994388
Other (OTH)
AF:
0.0592
AC:
3151
AN:
53238
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.435
Heterozygous variant carriers
0
2755
5511
8266
11022
13777
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1810
3620
5430
7240
9050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0887
AC:
11934
AN:
134576
Hom.:
573
Cov.:
20
AF XY:
0.0895
AC XY:
5855
AN XY:
65426
show subpopulations
African (AFR)
AF:
0.0962
AC:
3154
AN:
32772
American (AMR)
AF:
0.0999
AC:
1329
AN:
13302
Ashkenazi Jewish (ASJ)
AF:
0.0324
AC:
106
AN:
3276
East Asian (EAS)
AF:
0.0104
AC:
42
AN:
4026
South Asian (SAS)
AF:
0.113
AC:
446
AN:
3950
European-Finnish (FIN)
AF:
0.0969
AC:
950
AN:
9802
Middle Eastern (MID)
AF:
0.0659
AC:
17
AN:
258
European-Non Finnish (NFE)
AF:
0.0881
AC:
5682
AN:
64494
Other (OTH)
AF:
0.0950
AC:
174
AN:
1832
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
494
988
1483
1977
2471
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
134
268
402
536
670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0465
Hom.:
48

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ATXN1-related disorder Benign:1
Feb 28, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.11
Mutation Taster
=91/9
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs193922926; hg19: chr6-16327915; COSMIC: COSV55214920; COSMIC: COSV55214920; API